Cholera toxin structure, gene regulation and pathophysiological and immunological aspects.
Many notions regarding the function, structure and regulation of cholera toxin expression have remained essentially unaltered in the last 15 years. At the same time, recent findings have generated additional perspectives. For example, the cholera toxin genes are now known to be carried by a non-lytic bacteriophage, a previously unsuspected condition. Understanding of how the expression of cholera toxin genes is controlled by the bacterium at the molecular level has advanced significantly and relationships with cell-density-associated (quorum-sensing) responses have recently been discovered. Regarding the cell intoxication process, the mode of entry and intracellular transport of cholera toxin are becoming clearer. In the immunological field, the strong oral immunogenicity of the non-toxic B subunit of cholera toxin (CTB) has been exploited in the development of a now widely licensed oral cholera vaccine. Additionally, CTB has been shown to induce tolerance against co-administered (linked) foreign antigens in some autoimmune and allergic diseases.
Sánchez
J
J
Facultad de Medicina, UAEM, Av. Universidad 1001, Col. Chamilpa, Mexico.
Holmgren
J
J
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000235:genetics* / Q000494:pharmacology*; D001327:Autoimmune Diseases / Q000188:drug therapy; D001427:Bacterial Toxins / Q000494:pharmacology; D002771:Cholera / Q000382:microbiology; D002772:Cholera Toxin / Q000737:chemistry / Q000235:genetics* / Q000494:pharmacology*; D022121:Cholera Vaccines; D004768:Enterotoxins / Q000494:pharmacology; D029968:Escherichia coli Proteins / Q000494:pharmacology; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D018928:Immunity, Mucosal
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D022121:Cholera Vaccines; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli